Effect of ultrasound use on the pathological outcomes in temporal artery biopsy
Öz
Anahtar Kelimeler
Kaynakça
- 1. Turesson C, Börjesson O, Larsson K, Mohammad AJ, Knight A. Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis. Scandinavian Journal of Rheumatology 2019; 48: 1-7.
- 2. Mohammad AJ, Nilsson J-Å, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Annals of the Rheumatic Diseases 2015; 74: 993-7.
- 3. Wojczal J, Kozera G, Luchowski P, Neubauer-Geryk J. Advantages in diagnosis of giant cell arteritis by ultrasound. Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii 2019; 36: 25.
- 4. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Annals of Internal Medicine 1978; 88: 162-7.
- 5. Nesher G. The diagnosis and classification of giant cell arteritis. Journal of Autoimmunity 2014; 48: 73-5.
- 6. Font C, Cid MC, Coll-Vinent B, López-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. British Journal of Rheumatology 1997 ;36: 251-4.
- 7. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. The New England Journal of Medicine 2002; 347: 261-71.
- 8. Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nature Reviews Rheumatology 2012; 8: 509-21.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Fikret Şahintürk
*
Türkiye
Erkin Sönmez
Bu kişi benim
0000-0002-5693-3542
Türkiye
Çoşkun Araz
Bu kişi benim
0000-0002-4927-6660
Türkiye
Selim Ayhan
0000-0003-0153-3012
Türkiye
Cem Yılmaz
Türkiye
Yayımlanma Tarihi
29 Eylül 2021
Gönderilme Tarihi
11 Mayıs 2021
Kabul Tarihi
6 Eylül 2021
Yayımlandığı Sayı
Yıl 2021 Cilt: 12 Sayı: 3